Laboratory Tests for Evaluating Renal Function, Electrolyte Disturbances, Anemia, and Related Complications
Order a comprehensive initial laboratory panel including: complete blood count, serum electrolytes (sodium, potassium, chloride, calcium, magnesium), blood urea nitrogen, serum creatinine with eGFR calculation, urinalysis with urine albumin-to-creatinine ratio, fasting glucose or HbA1c, lipid profile, liver function tests, thyroid-stimulating hormone, serum ferritin, and transferrin saturation. 1, 2
Core Laboratory Panel
The initial evaluation should include:
Renal Function Assessment
- Serum creatinine and calculated eGFR - Essential for staging CKD and detecting acute kidney injury 1, 3, 4
- Blood urea nitrogen (BUN) - Helps assess volume status and renal function 1, 5
- Urinalysis - Screens for proteinuria, hematuria, and other urinary abnormalities 1, 3
- Urine albumin-to-creatinine ratio (UACR) - Critical for detecting and monitoring diabetic kidney disease; should be measured annually in patients with diabetes or known CKD 3, 4
Electrolyte Panel
- Sodium, potassium, chloride - Essential for detecting dysnatremias, hyperkalemia/hypokalemia, and acid-base disorders 1, 6, 5
- Calcium and magnesium - Important as these are frequently abnormal in CKD and can affect cardiac function 1, 2
- Serum bicarbonate (included in basic metabolic panel) - Screens for metabolic acidosis, common in advanced CKD 3, 5
Anemia Evaluation
- Complete blood count (CBC) with differential - Provides hemoglobin, hematocrit, mean corpuscular volume, white blood cell count, and platelet count 1, 2, 7
- Absolute reticulocyte count - Distinguishes between decreased production versus increased destruction/loss 7, 8
- Serum ferritin - Assesses iron stores 1, 7, 9
- Transferrin saturation (TSAT) - Evaluates iron availability for erythropoiesis 7, 9
Iron deficiency criteria differ in CKD patients: Absolute iron deficiency is defined as TSAT ≤20% with ferritin ≤100 ng/mL in non-dialysis/peritoneal dialysis patients or ≤200 ng/mL in hemodialysis patients. Functional iron deficiency shows TSAT ≤20% with elevated ferritin 7, 9.
Additional Initial Tests
- Fasting glucose or HbA1c - Screens for diabetes, a major cause of CKD 1, 2
- Lipid profile - Assesses cardiovascular risk 1, 2
- Liver function tests - Rules out hepatic causes of anemia and assesses overall health 1, 2
- Thyroid-stimulating hormone (TSH) - Thyroid disorders can cause both anemia and electrolyte abnormalities 1, 2
Advanced Testing When eGFR <60 mL/min/1.73 m²
Once CKD stage 3 or higher is identified, add:
- Serum phosphate - Elevated in CKD, contributes to mineral bone disease 3, 4
- Parathyroid hormone (PTH) - Screens for secondary hyperparathyroidism 3, 4
- 25-hydroxyvitamin D - Often deficient in CKD 3, 4
- Hemoglobin and iron studies - Monitor every 6-12 months for stage 3, every 3-5 months for stage 4, every 1-3 months for stage 5 4
Monitoring Frequency
Serial monitoring is critical and should be tailored to CKD stage:
- Stage 3 CKD: Every 6-12 months
- Stage 4 CKD: Every 3-5 months
- Stage 5 CKD: Every 1-3 months
- More frequent monitoring needed with therapy changes or symptom development 3, 4
Monitor serum electrolytes and renal function regularly in patients on:
- ACE inhibitors or ARBs (risk of hyperkalemia and acute kidney injury) 3, 2
- Diuretics (risk of hypokalemia, hyponatremia, volume depletion) 3, 2
- SGLT2 inhibitors (monitor for volume depletion, though AKI risk appears low) 3
Specialized Testing - Order Only When Indicated
For Suspected Acute Kidney Injury
- Urine sodium and chloride - Both should be measured to detect reduced effective intravascular volume; urine sodium <20 mEq/L and chloride <15 mEq/L suggest prerenal azotemia 6, 10, 11
- Fractional excretion of sodium - Helpful when diuretics not recently administered 10
- Urine sediment analysis - Identifies casts, cells indicating specific kidney pathology 12
For Unexplained Anemia
- Vitamin B12 and folate levels - Rule out megaloblastic anemia 7
- Serum erythropoietin level - Generally not needed; EPO deficiency is expected in CKD 9, 13
- Hemochromatosis screening or HIV testing - Only in selected patients with clinical suspicion 2
For Diabetic Ketoacidosis or Hyperosmolar State
- Serum ketones and arterial blood gas - Essential for diagnosis 5
- Serum osmolality - Calculated or measured 5
- Anion gap calculation - From basic metabolic panel 5
Critical Pitfalls to Avoid
Do not rely on serum creatinine alone - It lags behind actual GFR changes in acute settings and can be misleading in patients with low muscle mass 3, 12
Do not use standard iron deficiency criteria in CKD patients - Higher ferritin thresholds apply (100-200 ng/mL depending on dialysis status) because inflammation elevates ferritin 7, 9
Do not order 24-hour urine collections for creatinine clearance routinely - Only useful in stable chronic conditions; spot UACR is preferred for albuminuria screening 3, 12
Do not interpret urine electrolytes without considering diuretic use - Diuretics invalidate interpretation of urine sodium for volume assessment 6, 10, 11
Do not forget to check potassium before and after starting RAAS inhibitors - Hyperkalemia is a common and potentially dangerous complication 3, 2